Comparison between Neurectomy and Botulinum Toxin A Injection for Denervated Skeletal Muscle
Abstract
Neurectomy and botulinum toxin A (BoNT-A) injection cause denervated muscle atrophy, but questions remain about their clinical utility. We investigated time-series alterations of rat muscle weight, functional deficits, signaling pathways, and microscopic structures, to gain an understanding of the clinical implications. Between 2008 and 2009, the maximal calf circumference of patients for calf reduction either by neurectomy or BoNT-A injections were recorded for study. A rat skeletal muscle model was established through repeated or dose-adjusted BoNT-A injections and neurectomy. The survival, apoptosis pathways, functional deficits, and microscopic structures were investigated using Western blot, sciatic functional index (SFI), and transmission electron microscopy (TEM), respectively. The rat muscle weight ratio of the BoNT-A group had recovered to 89.3 ± 3.8% by week 58, but it never recovered in the neurectomy group. Muscle weight reduction by BoNT-A not only depended on the dose, but additive effects were also obtained through repeated injections. Rat SFI demonstrated rapid recovery in both groups. Molecular expressions showed a coherent and biphasic pattern. p-Akt and apoptosis-inducing factor (AIF) were upregulated significantly, with a peak at 8 weeks in the neurectomy group (p < 0.01), but cleaved caspase-9 and caspase-3 showed no significant changes in either group. TEM findings showed irreversible and reversible inner-structure disruption and sarcomere discontinuity in the neurectomy and BoNT-A groups, respectively. We demonstrated that denervation induced lasting muscle weight and structural changes of different degrees. Muscle weight reduction by BoNT-A was related to frequency and dose. AIF-mediated caspase-independent apoptosis was significantly different for neurectomy and BoNT-A injection.
Get full access to this article
View all available purchase options and get full access to this article.
References
Adhihetty P.J.O'Leary M.F.N.Chabi B.2007. Effect of denervation on mitochondrially mediated apoptosis in skeletal muscleJ. Appl. Physiol.1021143-1151. Adhihetty, P.J., O'Leary, M.F.N., and Chabi, B. (2007). Effect of denervation on mitochondrially mediated apoptosis in skeletal muscle. J. Appl. Physiol. 102, 1143–1151.
Ahn K.Y.Kim S.T.2007. The change of maximum bite force after botulinum toxin type A injection for treating masseteric hypertrophyPlast. Reconstr. Surg.1201662-1666. Ahn, K.Y., and Kim, S.T. (2007). The change of maximum bite force after botulinum toxin type A injection for treating masseteric hypertrophy. Plast. Reconstr. Surg. 120, 1662–1666.
Bain J.R.Mackinnon S.E.Hunter R.T.1989. Functional evaluation of complete sciatic, peroneal and posterior tibial nerve lesions in the ratPlast. Reconstr. Surg.83129-138. Bain, J.R., Mackinnon, S.E., and Hunter, R.T. (1989). Functional evaluation of complete sciatic, peroneal and posterior tibial nerve lesions in the rat. Plast. Reconstr. Surg. 83, 129–138.
Bodine S.C.Stitt T.N.Gonzalez M.Kline W.O.Stover G.L.Bauerlein R.2001. Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivoNat. Cell Biology31014-1019. Bodine, S.C., Stitt, T.N., Gonzalez, M., Kline, W.O., Stover, G.L., and Bauerlein, R. (2001). Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat. Cell Biology 3, 1014–1019.
Chiu S.M.Xue L.Y.Usuda J.Azizuddin K.Oleinick N.L.2003. Bax is essential for mitochondria-mediated apoptosis but not for cell death caused for photodynamic therapyBr. J. Cancer891590-1597. Chiu, S.M., Xue, L.Y., Usuda, J., Azizuddin, K., and Oleinick, N.L. (2003). Bax is essential for mitochondria-mediated apoptosis but not for cell death caused for photodynamic therapy. Br. J. Cancer 89, 1590–1597.
Chuang D.C.2009. Adult brachial plexus reconstruction with the level of injury: review and personal experiencePlast. Reconstr. Surg.124e359-e369. Chuang, D.C. (2009). Adult brachial plexus reconstruction with the level of injury: review and personal experience. Plast. Reconstr. Surg. 124, e359–e369.
Davatz G.C.Andreo J.C.Rodrigues A.C.Rosa Junior G.M.Moraes L.H.R.2007. Apoptosis in denervated skeletal muscleInt. J. Morphol.25529-536. Davatz, G.C., Andreo, J.C., Rodrigues, A.C., Rosa Junior, G.M., and Moraes, L.H.R. (2007). Apoptosis in denervated skeletal muscle. Int. J. Morphol. 25, 529–536.
Ferreira R.Neuparth M.J.Vitorino R.Appell H.J.Amado F.Durate J.A.2008. Evidences of apoptosis during the early phases of soleus muscle atrophy in hindlimb suspended micePhysiol. Res.57601-611. Ferreira, R., Neuparth, M.J., Vitorino, R., Appell, H.J., Amado, F., and Durate, J.A. (2008). Evidences of apoptosis during the early phases of soleus muscle atrophy in hindlimb suspended mice. Physiol. Res. 57, 601–611.
Franke T.F.Yang S.I.Chan T.O.1995. The protein kinase encoded by the Akt proto-oncogene is a target of PDGF-activated phosphoinositide 3-kinaseCell81727-736. Franke, T.F., Yang, S.I., and Chan, T.O. (1995). The protein kinase encoded by the Akt proto-oncogene is a target of PDGF-activated phosphoinositide 3-kinase. Cell 81, 727–736.
Harii K.Kawashima M.2008. A double-blind, randomized, placebo-controlled, two-dose comparative study of botulinum toxin type A for treating glabellar lines in Japanese subjectsAesthetic Plast. Surg.32724-730. Harii, K., and Kawashima, M. (2008). A double-blind, randomized, placebo-controlled, two-dose comparative study of botulinum toxin type A for treating glabellar lines in Japanese subjects. Aesthetic Plast. Surg. 32, 724–730.
Hatoko M.Niitsuma K.Tanaka A.2004. Expression of N-Cadherin and α N-Catenin in the degeneration/regeneration process of rat skeletal muscle after nerve injuryJ. Reconstr. Microsurg.20267-273. Hatoko, M., Niitsuma, K., and Tanaka, A. (2004). Expression of N-Cadherin and α N-Catenin in the degeneration/regeneration process of rat skeletal muscle after nerve injury. J. Reconstr. Microsurg. 20, 267–273.
Hoare B.J.Wallen M.A.Imms C.Villanueva E.Rawicki H.B.Carey L.2010. Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral palsy (UPDATE)Cochrane Database Syst. Rev.20CD003469. Hoare, B.J., Wallen, M.A., Imms, C., Villanueva, E., Rawicki, H.B., and Carey, L. (2010). Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral palsy (UPDATE). Cochrane Database Syst. Rev. 20, CD003469.
Kim K.S.Byun Y.S.Kim Y.J.Kim S.T.K.2009. Muscle weakness after repeated injection of botulinum toxin type A evaluated according to bite force measurement of human masseter muscle? DermatolSurg.351902-1907. Kim, K.S., Byun, Y.S., Kim, Y.J., and Kim, S.T.K. (2009). Muscle weakness after repeated injection of botulinum toxin type A evaluated according to bite force measurement of human masseter muscle? Dermatol. Surg. 35, 1902–1907.
Jackman R.W.Kandarian S.C.2004. The molecular basis of skeletal muscle atrophyAm. J. Physiol. Cell Physiol.287834-843. Jackman, R.W., and Kandarian, S.C. (2004). The molecular basis of skeletal muscle atrophy. Am. J. Physiol. Cell Physiol. 287, 834–843.
Jeng S.F.Rau C.S.Liliang P.C.Wu C.J.Lu T.H.Chen Y.H.Lin C.J.Hsieh C.H.2009. Profiling muscle-specific microRNA expression after peripheral denervation and reinnervation in a rat modelJ. Neurotrauma262345-2553. Jeng, S.F., Rau, C.S., Liliang, P.C., Wu, C.J., Lu, T.H., Chen, Y.H., Lin, C.J., and Hsieh, C.H. (2009). Profiling muscle-specific microRNA expression after peripheral denervation and reinnervation in a rat model. J. Neurotrauma 26, 2345–2553.
Lee C.J.Kim S.G.Kim Y.J.Han J.Y.Choi S.H.Lee S.I.2007. Electrophysiologic change and facial contour following botulinum toxin A injection in square facesPlast. Reconstr. Surg.120769-778. Lee, C.J., Kim, S.G., Kim, Y.J., Han, J.Y., Choi, S.H., and Lee, S.I. (2007). Electrophysiologic change and facial contour following botulinum toxin A injection in square faces. Plast. Reconstr. Surg. 120, 769–778.
Lee H.J.Lee D.W.Park Y.H.Cha M.K.Kim H.S.Ha S.J.2004. Botulinum toxin A for aesthetic contouring of enlarged medial gastrocnemius muscleDermatol. Surg.30867-871. Lee, H.J., Lee, D.W., Park, Y.H., Cha, M.K., Kim, H.S., and Ha, S.J. (2004). Botulinum toxin A for aesthetic contouring of enlarged medial gastrocnemius muscle. Dermatol. Surg. 30, 867–871.
Ma J.Elsaidi G.A.Smith T.L.2004. Time course of recovery of juvenile skeletal muscle after botulinum toxin A injection: an animal model studyAm. J. Phys. Med. Rehabil.83774-780. Ma, J., Elsaidi, G.A., and Smith, T.L. (2004). Time course of recovery of juvenile skeletal muscle after botulinum toxin A injection: an animal model study. Am. J. Phys. Med. Rehabil. 83, 774–780.
Marzetti E.Hwang J.C.Y.Lees H.A.2010. Mitochondrial death effectors: relevance to sarcopenia and disuse muscle atrophyBiochim. Biophys. Acta.1800235-244. Marzetti, E., Hwang, J.C.Y., and Lees, H.A. (2010). Mitochondrial death effectors: relevance to sarcopenia and disuse muscle atrophy. Biochim. Biophys. Acta. 1800, 235–244.
Namikawa K.Honma M.Abe K.2000. Akt/protein kinase B prevents injury induced motoneuron death and accelerates axonal regenerationJ. Neurosci.202875-2886. Namikawa, K., Honma, M., and Abe, K. (2000). Akt/protein kinase B prevents injury induced motoneuron death and accelerates axonal regeneration. J. Neurosci. 20, 2875–2886.
Pospisilik J.A.Knauf C.Joza N.Benit P.2007. Targeted deletion of AIF decreases mitochondrial oxidative phosphorylation and protects from obesity and diabetesCell131476-491. Pospisilik, J.A., Knauf, C., Joza, N., and Benit, P. (2007). Targeted deletion of AIF decreases mitochondrial oxidative phosphorylation and protects from obesity and diabetes. Cell 131, 476–491.
Rogozhin A.A.Pang K.K.Bukharaeva E.Young C.Slater C.R.2008. Recovery of mouse neuromuscular junctions from single and repeated injections of botulinum neurotoxinAm. J. Physiol.5863163-3182 Rogozhin, A.A., Pang, K.K., Bukharaeva, E., Young, C., and Slater, C.R. (2008) Recovery of mouse neuromuscular junctions from single and repeated injections of botulinum neurotoxin Am. J. Physiol. 586, 3163–3182
Schwaiger F.W.Hager G.Schmitt A.B.2000. Peripheral but not central axotomy induces changes in Janus kinases (JAK) and signal transducers and activators of transcription (STAT)Eur. J. Neurosci.121165-1176. Schwaiger, F.W., Hager, G., and Schmitt, A.B. (2000). Peripheral but not central axotomy induces changes in Janus kinases (JAK) and signal transducers and activators of transcription (STAT). Eur. J. Neurosci. 12, 1165–1176.
Shen J.Ma J.Lee C.Smith B.P.Smith T.L.Tan K.H.Koman L.A.2006. How muscles recover from paresis and atrophy after intramuscular injection of botulinum toxin A: study in juvenile ratsJ. Orthop. Res.241128-1135. Shen, J., Ma, J., Lee, C., Smith, B.P., Smith, T.L., Tan, K.H., and Koman, L.A. (2006). How muscles recover from paresis and atrophy after intramuscular injection of botulinum toxin A: study in juvenile rats. J. Orthop. Res. 24, 1128–1135.
Siu P.M.Always S.E.2005. Mitochondria-associated apoptotic signaling in denervated rat skeletal muscleJ. Physiol.565309-323. Siu, P.M., and Always, S.E. (2005). Mitochondria-associated apoptotic signaling in denervated rat skeletal muscle. J. Physiol. 565, 309–323.
Song Y.H.Li Y.Du J.Mitch W.E.Rosenthal N.Delafontaine P.2005. Muscle-specific expression of IGF-1 blocks angiotensin II-induced skeletal muscle wastingJ. Clin. Invest.115451-458. Song, Y.H., Li, Y., Du, J., Mitch, W.E., Rosenthal, N., and Delafontaine, P. (2005). Muscle-specific expression of IGF-1 blocks angiotensin II-induced skeletal muscle wasting. J. Clin. Invest. 115, 451–458.
Tang H.Cheung W.M.W.Ip F.C.Ip N.Y.2000. Identification and characterization of differentially expressed genes in denervated muscleMol. Cell Neurosci.12127-140. Tang, H., Cheung, W.M.W., Ip, F.C., and Ip, N.Y. (2000). Identification and characterization of differentially expressed genes in denervated muscle. Mol. Cell Neurosci. 12, 127–140.
Terzis J.K.Kostopoulos V.K.2010. Vascularized nerve grafts for lower extremity nerve reconstructionAnn. Plast. Surg.64169-176. Terzis, J.K., and Kostopoulos, V.K. (2010). Vascularized nerve grafts for lower extremity nerve reconstruction. Ann. Plast. Surg. 64, 169–176.
Tsai F.C.Mardini S.Fong T.H.Kang J.H.Chou C.M.2008. Selective neurectomy of the gastrocnemius and soleus muscles for calf hypertrophy: an anatomical study and 700 clinical casesPlast. Reconstr. Surg.122178-187. Tsai, F.C., Mardini, S., Fong, T.H., Kang, J.H., and Chou, C.M. (2008). Selective neurectomy of the gastrocnemius and soleus muscles for calf hypertrophy: an anatomical study and 700 clinical cases. Plast. Reconstr. Surg. 122, 178–187.
Vahsen N.Cande C.Briere J.J.2004. AIF deficiency compromises oxidative phosphorylationEMBO J.234679-4689. Vahsen, N., Cande, C., and Briere, J.J. (2004). AIF deficiency compromises oxidative phosphorylation. EMBO J. 23, 4679–4689.
Walsh S.Midha R.2009. Use of stem cells to augment nerve injury repairNeurosurgery6580-86. Walsh, S., and Midha, R. (2009). Use of stem cells to augment nerve injury repair. Neurosurgery 65, 80–86.
White C.M.Greensmith L.Vrbova G.2000. Repeated stimuli for axonal growth causes motorneuron death in adult rats: the effect of botulinum toxin followed by partial denervationNeuroscience951101-1109. White, C.M., Greensmith, L., and Vrbova, G. (2000). Repeated stimuli for axonal growth causes motorneuron death in adult rats: the effect of botulinum toxin followed by partial denervation. Neuroscience 95, 1101–1109.
Wissing S.2004. An AIF orthologue regulates apoptosis in yeastJ. Cell Biol.166969-974. Wissing, S. (2004). An AIF orthologue regulates apoptosis in yeast. J. Cell Biol. 166, 969–974.
Information & Authors
Information
Published In

Copyright
Copyright 2010, Mary Ann Liebert, Inc.
History
Published online: 16 August 2010
Published in print: August 2010
Published ahead of production: 7 June 2010
Authors
Author Disclosure Statement
No competing financial interests exist.
Metrics & Citations
Metrics
Citations
Export Citation
Export citation
Select the format you want to export the citations of this publication.
View Options
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.⚠ Society Access
If you are a member of a society that has access to this content please log in via your society website and then return to this publication.